Compensation dips slightly for WellPoint brass

Back to TopCommentsE-mailPrintBookmark and Share

Compensation fell slightly for WellPoint Inc.’s top executives last year as the company doled out smaller stock awards and bonuses, the company reported Monday night in its annual proxy statement.

Angela Braly, CEO of the Indianapolis-based health insurance giant, received total compensation of nearly $13.3 million, down 1.5 percent from the $13.5 million she made the previous year.

Braly’s salary was unchanged at $1.4 million, but she received an $8 million stock grant, which was nearly 50 percent larger than in 2010. Braly received fewer stock options, however, and her incentive-based bonus of $1.9 million was 32 percent less than in the previous year.

WellPoint’s other top brass also saw their total compensation shrink as the value of their stock-option grants and incentive-based bonus pay shrank.

Chief Financial Officer Wayne DeVeydt received $3.9 million in 2011, or 3.9 percent less than in the previous year.

Ken Goulet, WellPoint’s executive vice president over employer, Medicaid, individual and specialty insurance lines, got $3.7 million, or 1.4 percent less than the previous year.

Lori Beer, executive vice president for enterprise business services, received a big stock grant when she first joined WellPoint’s ranks of top five executives in 2010. But she received a much smaller amount of stock last year. That helped to reduce her pay by 39 percent, to $2.7 million.

And Brian Sassi, who WellPoint dismissed in January for performance reasons, saw his compensation plummet by 45 percent, to $3 million. His bonus pay dropped by 60 percent and his stock grant was nearly cut in half compared with 2010.

The compensation committee of WellPoint’s board of directors lauded its executives for helping to boost WellPoint’s earnings per share in 2011, juicing its health plans’ enrollment by more than 900,000, reducing overhead expenses by nearly $300 million and instituting WellPoint’s first dividend payments.

WellPoint’s overall profit, however, declined by 8 percent, to $2.65 billion, compared with the previous year.

WellPoint’s stock price rose 17 percent in 2011, closing the year at $66.25 per share. But most of its peers did significantly better in the stock market. The stock prices of of Louisville-based Humana Inc., Minnesota-based UnitedHealth Group and Hartford-based Aetna Inc. rose, respectively, 52 percent, 40 percent and 38 percent last year.

Company stock was down 14 cents Tuesday morning, to $72.81 per share.


  • Yes
  • class warfare??
    I wonder why the IBJ prints articles like this. Does anyone cry foul when Maning makes 20 million a year? Wellpoints executive compensation is inline with other companies of it's size. Hey if you don't like wellpoint - blame the government for limiting across state line competition of insurance companies, or just pick one of many other insurers in the state.
  • Wellpoint LOVES Obamacare
    They've lubed the administration and Congress very effectively with their lobbyists. Obamacare will be a huge windfall for Wellpoint and other insurance companies as more and more people will be forced to get health insurance. And although all of the rest of us will be paying the price, I'm sure Wellpoint executives will feel they deserve large bonuses for a job well done.
  • Sammie
    Too bad patients have to fight to get their surgeries approved. Guess they want enrollees to keep paying these bonuses & the company not pay for needed procedures
  • How Will She Feed Her Family
    How is she going to feed her family on such a meager compensation package? I shutter to think.
  • Wellpoint Compensation
    How in the world can she get by when her comp is reduce by $200,000? Frickin' Obamacare.

    Post a comment to this story

    We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
    You are legally responsible for what you post and your anonymity is not guaranteed.
    Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
    No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
    We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

    Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

    Sponsored by

    facebook - twitter on Facebook & Twitter

    Follow on TwitterFollow IBJ on Facebook:
    Follow on TwitterFollow IBJ's Tweets on these topics:
    thisissue1-092914.jpg 092914

    Subscribe to IBJ